These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27780857)

  • 1. Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational Agents.
    Chuk MK; Mulugeta Y; Roth-Cline M; Mehrotra N; Reaman GH
    Clin Cancer Res; 2017 Jan; 23(1):9-12. PubMed ID: 27780857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reviewing concomitant medications for participants in oncology clinical trials.
    McGahey KE; Weiss GJ
    Am J Health Syst Pharm; 2017 Apr; 74(8):580-586. PubMed ID: 28389457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group.
    Gore L; Ivy SP; Balis FM; Rubin E; Thornton K; Donoghue M; Roberts S; Bruinooge S; Ersek J; Goodman N; Schenkel C; Reaman G
    J Clin Oncol; 2017 Nov; 35(33):3781-3787. PubMed ID: 28968169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilemmas in the compassionate supply of investigational cancer drugs.
    Lewis JR; Lipworth W; Kerridge I; Doran E
    Intern Med J; 2014 Sep; 44(9):841-5. PubMed ID: 25201421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections.
    Kim J; Singh H; Ayalew K; Borror K; Campbell M; Johnson LL; Karesh A; Khin NA; Less JR; Menikoff J; Minasian L; Mitchell SA; Papadopoulos EJ; Piekarz RL; Prohaska KA; Thompson S; Sridhara R; Pazdur R; Kluetz PG
    Clin Cancer Res; 2018 Apr; 24(8):1780-1784. PubMed ID: 29237718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
    Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
    Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits.
    Fountzilas E; Said R; Tsimberidou AM
    Expert Opin Investig Drugs; 2018 Feb; 27(2):155-162. PubMed ID: 29353505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing oncology research protocols.
    Lunik MC
    Top Hosp Pharm Manage; 1994 Jul; 14(2):11-21. PubMed ID: 10136201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Researchers may use cancer cell lines to identify target populations prior to clinical trials.
    Tuma RS
    J Natl Cancer Inst; 2006 Jun; 98(12):810-1. PubMed ID: 16788154
    [No Abstract]   [Full Text] [Related]  

  • 12. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
    Vassal G; Rousseau R; Blanc P; Moreno L; Bode G; Schwoch S; Schrappe M; Skolnik J; Bergman L; Bradley-Garelik MB; Saha V; Pearson A; Zwierzina H
    Eur J Cancer; 2015 Jan; 51(2):218-24. PubMed ID: 25434924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug development in paediatric oncology].
    Benninger-Döring G; Boos J
    Klin Padiatr; 2006; 218(3):152-6. PubMed ID: 16688671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japan works to shorten "drug lag," boost trials of new drugs.
    Sinha G
    J Natl Cancer Inst; 2010 Feb; 102(3):148-51. PubMed ID: 20107160
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy of older persons with acute myeloid leukemia.
    Gale RP; Hochhaus A
    Leukemia; 2015 Apr; 29(4):759. PubMed ID: 25614196
    [No Abstract]   [Full Text] [Related]  

  • 16. Current issues surrounding women and minorities in drug trials.
    Wermeling DP; Selwitz AS
    Ann Pharmacother; 1993; 27(7-8):904-11. PubMed ID: 8364277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' rights a case for a Charter of Participant Rights in Pre-Market Drug Trials: the next evolution.
    Sheldon CT; Ferris LE
    Med Law; 2010 Jun; 29(2):239-61. PubMed ID: 22462288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food and Drug Administration responds to pressure for expanded drug access.
    Brower V
    J Natl Cancer Inst; 2014 Jun; 106(6):dju171. PubMed ID: 24907387
    [No Abstract]   [Full Text] [Related]  

  • 19. Expansion Cohorts in First-in-Human Solid Tumor Oncology Trials.
    Theoret MR; Pai-Scherf LH; Chuk MK; Prowell TM; Balasubramaniam S; Kim T; Kim G; Kluetz PG; Keegan P; Pazdur R
    Clin Cancer Res; 2015 Oct; 21(20):4545-51. PubMed ID: 26473190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut Curie.
    Surun A; Dujaric MÉ; Aerts I; Orbach D; Jiménez I; Pacquement H; Schleiermacher G; Bourdeaut F; Michon J; Dupont JK; Doz F
    Pediatr Blood Cancer; 2018 May; 65(5):e26916. PubMed ID: 29334194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.